Fundraising FoxFind your path to Carol
150 people in our graph can introduce you to Carol.
Sign up to see every warm intro you have to Carol
- Paths you didn't know you had: your email and LinkedIn already hold routes to Carol. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Carol Collins is a Strategic Advisor at VERISIAN with 30 years of experience in the global life sciences and healthcare sector, including CRO, pharma services, clinical development and commercialisation, digital healthcare communications, MedTech, and healthcare data organisations. She has held CEO, C-suite, and non-executive director roles, with expertise spanning strategic, financial, and commercial planning, governance, regulatory oversight, risk management, and fund-raising. Collins currently serves as a strategic advisor or non-executive director to management teams and investors at companies ranging from pre-seed to private-equity funded.
Experience
- VERISIANStrategic Advisorcurrent2026 — present
- SONAStrategic Advisor and Clinical Directorcurrent2025 — present
- VariousStrategic Advisor and Non-Executive Directorcurrent2025 — presentLondon Area, United Kingdom
- ClarivateHealth Sustainability, Clarivate2021 — 2025
- The Edgewater FundsHealthcare Advisory Board Member (Non-Executive)2022 — 2024
- Patient Connect LimitedBoard Director / Chief Commercial Officer2017 — 2022
- Patient Connect LimitedNon Executive Director2016 — 2017
- Viroclinics Biosciences BVNon Exective Director / Supervisory Board Member2017 — 2018The Randstad, Netherlands
- PAREXELCorporate Vice President1998 — 2016
- TIL Occam LtdChief Executive Officer1995 — 1998
Skills & more
Pharmaceutical Industry10CRO7Clinical Development11Clinical Trials8Change Management3Real World Evidence1Strategic Leadership1Business Strategy1Board of DirectorsStrategic PartnershipsStrategic Planning1Corporate Development
+10 more
LeadershipDrug DevelopmentClinical ResearchBiotechnologyGCPCTMSTeam BuildingStrategic ConsultingGood Clinical Practice (GCP)CRO ManagementFrom Carol's professional profile.
Colleagues at Edgewater Funds
Andres Toro
Board Member at Edgewater Funds
Andrew J. McKenna
Honorary Chairman of the Board at Edgewater Funds
Aria Duan
Senior Financial Accountant at Edgewater Funds
Ava Van Vleck
Business Development Analyst at Edgewater Funds
Bill Hughson
Board Member (Healthcare Executive Advisory Board) at Edgewater Funds
Bob Trinh
Board Member (Healthcare Executive Advisory Board) at Edgewater Funds
Brennan Smith
Vice President of Business Development at Edgewater Funds
Christopher E. Banas
Board Member (Healthcare Executive Advisory Board) at Edgewater Funds
Frequently asked questions
- Who is Carol Collins?
- Carol Collins is a Strategic Advisor at VERISIAN with 30 years of experience in the global life sciences and healthcare sector, including CRO, pharma services, clinical development and commercialisation, digital healthcare communications, MedTech, and healthcare data organisations. She has held CEO, C-suite, and non-executive director roles, with expertise spanning strategic, financial, and commercial planning, governance, regulatory oversight, risk management, and fund-raising. Collins currently serves as a strategic advisor or non-executive director to management teams and investors at companies ranging from pre-seed to private-equity funded.
- Where does Carol Collins work?
- Carol Collins is Board Member (Healthcare Advisory Board) at Edgewater Funds.
- Where did Carol Collins go to school?
- Carol Collins studied at London Business School (MBA, Business Administration and Management); Harvard Medical School (AI in Healthcare); University of East Anglia (Doctor of Philosophy (PhD), Neuroscience).
Same school
Also attended London Business School986
Patrick ClaessenPartner at Cottonwood Technology FundDominic JacquessonInvestor at Index VenturesSandra SchwarzerInvestor at Index VenturesMatt CherianVenture Partner at Monta Vista CapitalAkshat GoenkaInvestor at Moonfire VenturesGiuseppe IademarcoHead of Global Partnership at P101 Ventures
+ 980 more
Also attended Harvard Medical School336
Niko BonatsosFounder and Managing Partner of VerdictAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
+ 330 more
Also attended University of East Anglia53
Ulili OnovakpuriManaging Partner at Kapor CapitalMaarten 't HooftManaging Partner and Founder at Quest Venture PartnersCiaran RooneyInvestor at FELIX CAPITALSarah TurnerCo-founder & CEO at Angel AcademePaul MascarenasVenture Partner at Fontinalis PartnersMaggie AndrewsSenior Director at NewSchools Venture Fund
+ 47 more
Shared employers
Also worked at SONA1
Also worked at Clarivate13
Andreas PanayiotouAuthor of Monetisation Matters, writing on strategy and monetisation for founders, product, and product marketing leadersChris Rios-VillalobosSenior Associate at Chartline Capital PartnersJan ReicheltInvestment Team at 10x FoundersJack HennessyInvestor at BPEA EQTVictoria OtamiriInvestor at Endurance28Bojan JovićMember of Supervisor Committee at TS Ventures
+ 7 more
Also worked at The Edgewater Funds21
M. Troy PhillipsPartner at BPOCKent BerkleyPartner at Frazier Healthcare PartnersWillInvestor at Koyamaki VenturesTaniya GaurVice President at Tritium PartnersDavid TolmieSenior Partner at Edgewater FundsMatthew SnyderChief Operating Officer and Senior Partner at Edgewater Funds
+ 15 more
